Finally, to evaluate the clinical significance of FAP and DAB2, we further included 90 HCC tumor boundary samples for IHC staining, in which FAP+ CAFs and DAB2+ TAMs enriched around the tumor core (Figure 7A). The gene discussed is DAB2; the disease is hepatocellular carcinoma.